| Description | Sodium taurodeoxycholate hydrate (Taurodeoxycholic acid sodium salt monohydrate) has been used in a study to assess the effect of submicellar concentrations of bile salts on the lipid bilayer membrane. |
| Synonyms | 牛磺去氧胆酸钠, Taurodeoxycholic acid sodium salt monohydrate |
| molecular weight | 539.7 |
| Molecular formula | C26H44NO6S.Na.H2O |
| CAS | 207737-97-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: 27.5 mg/ml (50.95 mM) |
| References | 1. Barbara, Orioni, Mauro, et al. Polymorphic Behavior in Protein−Surfactant Mixtures: The Water−Bovine Serum Albumin−Sodium Taurodeoxycholate System[J]. Journal of Physical Chemistry B, 2006. |
| Citations | 1. Qiu Q, Guo G, Guo X, et al.P53 Deficiency Accelerate Esophageal Epithelium Intestinal Metaplasia Malignancy.Biomedicines.2023, 11(3): 882. |
Sodium taurodeoxycholate hydrate
CAS No.: 207737-97-1
Sodium taurodeoxycholate hydrate (Taurodeoxycholic acid sodium salt monohydrate) has been used in a study to assess the
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.